BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
The post Lynparza has been approved for BRCA-mutated advanced ovarian cancer appeared first on European Pharmaceutical Review.
Original Article: Lynparza has been approved for BRCA-mutated advanced ovarian cancer